SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,600.00    14.00 (0.31%)
Bid:
4,578.00
Ask:
3,900.00
Spread: -678.00 (-14.81%)
Market Cap: £16.71b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director Declaration

11 May 2026 09:00

RNS Number : 7840D
Coca-Cola HBC AG
11 May 2026
 

Coca-Cola HBC AG

Director Declaration

 

Zug, Switzerland 11 May 2026 - Coca-Cola HBC AG ("Coca-Cola HBC") announces that Stavros Pantzaris, Independent non-Executive Director, has been appointed as a director of TITAN S.A. (Euronext Brussels, Paris and Euronext Athens, under the ticker symbol "TITC") with effect from 8 May 2026.

This disclosure is made pursuant to paragraph 6.4.9R of the UK Listing Rules.

 

Enquiries

Coca-Cola HBC Group

Investors and Analysts:

Jemima Benstead

Head of Investor Relations

Tel: +44 7740 535130

 jemima.benstead @cchellenic.com

Elias Davvetas

Investor Relations Manager

Tel: +30 694 7568826

elias.davvetas@cchellenic.com

Matilde Durazzano

Investor Relations Manager

 

Elizabeth King

Investor Relations Manager

 

Tel: +44 7851 105884

matilde.durazzano@cchellenic.com

 

Tel: +44 7864 686582

elizabeth.king@cchellenic.com

Media:

Sonia Bastian

Head of Communications

 

Claire Evans

Head of Corporate Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

 

Tel: +44 7896 054 972

claire.evans @cchellenic.com

 

Coca-Cola HBC Group

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all, by creatingvalue for our stakeholders andsupporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 760 million consumers across a broad geographic footprint of 29 countries.Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading brands across the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories, with snacks as an additional offering. Our products include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano,Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Plazma. We foster an open and inclusive work environment for our more than 33,500 employees and believe that a positive environmental impact is integral to our future growth. We are among the leaders of the global beverage industry across major sustainability benchmarks, including the Dow Jones Best-in-Class Indices, CDP, MSCI ESG,FTSE ESGand ISS ESG. 

Coca-Cola HBC is listed on the London Stock Exchange (LSE: CCH) and on Euronext Athens (Euronext Athens: EEE). For more information, please visit https://www.coca-colahellenic.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNGRGDUGSBDGLB
Date   Source Headline
19th Jun 20245:14 pmRNSTransaction in Own Shares
18th Jun 20245:09 pmRNSTransaction in Own Shares
18th Jun 20244:23 pmRNSDirector/PDMR Shareholding
17th Jun 20245:20 pmRNSTransaction in Own Shares
14th Jun 20245:11 pmRNSTransaction in Own Shares
14th Jun 20247:09 amRNSTransaction in Own Shares
11th Jun 20245:41 pmRNSTransaction in Own Shares
10th Jun 20245:25 pmRNSTransaction in Own Shares
5th Jun 20245:32 pmRNSTransaction in Own Shares
4th Jun 20245:28 pmRNSTransaction in Own Shares
3rd Jun 20245:19 pmRNSTransaction in Own Shares
3rd Jun 20244:11 pmRNSIssue of Equity and total voting rights
31st May 20245:25 pmRNSTransaction in Own Shares
30th May 20245:36 pmRNSTransaction in Own Shares
29th May 20243:25 pmRNSDirector/PDMR Shareholding
29th May 20243:19 pmRNSDirector/PDMR Shareholding
28th May 202410:07 amRNSDirector/PDMR Shareholding
28th May 202410:04 amRNSDirector/PDMR Shareholding
22nd May 20245:43 pmRNSDirector/PDMR Shareholding
21st May 20246:01 pmRNSComposition of the Board Committees
21st May 20245:55 pmRNSResult of AGM
20th May 20244:44 pmRNSDirector/PDMR Shareholding
15th May 20244:19 pmRNSDirector/PDMR Shareholding
13th May 202411:30 amRNSDirector/PDMR Shareholding
8th May 20245:50 pmRNSTransaction in Own Shares
7th May 20245:29 pmRNSTransaction in Own Shares
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement
22nd Mar 20245:05 pmRNSTransaction in Own Shares
21st Mar 20245:40 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.